Results 31 to 40 of about 221,385 (308)
Background: One in 200 infants in the UK is born extremely prematurely, i.e. before 29 weeks of gestation. Seventy-five per cent of such infants survive, but many have long-term respiratory and/or functional problems.
Anne Greenough +6 more
doaj +1 more source
The future outlook on allergen immunotherapy in children: 2018 and beyond. [PDF]
Allergen immunotherapy (AIT) is the only currently available immune-modifying and aetiological treatment for patients suffering from IgE-mediated diseases.
Arasi S, Corsello G, Pajno GB, Villani A
core +2 more sources
BackgroundGrowing evidence has well documented the close association between the gut microbiome and allergic respiratory disease, which has been notably represented by allergic asthma.
Wei Wan +5 more
doaj +1 more source
Investigating the association between obesity and asthma in 6- to 8-year-old Saudi children:a matched case-control study [PDF]
Background: Previous studies have demonstrated an association between obesity and asthma, but there remains considerable uncertainty about whether this reflects an underlying causal relationship.
A Bener +52 more
core +2 more sources
Complements and allergic asthma
Regulatory T (Treg) cells play a central role in protecting against the development of allergic asthma and interleukin-10 (IL-10) producing T regulatory type 1 (Tr1) cells contribute to the regulation of asthma. Complement regulatory protein CD46 was shown to stimulate the development of IL-10 producing Tr1 cells.
Ching-Yuang Lin, Yi-Giien Tsai
openaire +2 more sources
Omalizumab for Severe Asthma: Beyond Allergic Asthma [PDF]
Different subsets of asthma patients may be recognized according to the exposure trigger and the frequency and severity of clinical signs and symptoms. Regarding the exposure trigger, generally asthma can be classified as allergic (or atopic) and nonallergic (or nonatopic). Allergic and nonallergic asthma are distinguished by the presence or absence of
C. C. Loureiro +7 more
openaire +5 more sources
Allergen Immunotherapy in Asthma
Allergen immunotherapy (AIT) is a specific treatment involving the administration of relevant allergens to allergic patients, with subtypes including subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT).
Kazuyuki Nakagome, Makoto Nagata
doaj +1 more source
Allergic bronchopulmonary aspergillosis: diagnostic and treatment challenges [PDF]
Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder, occurring mostly in asthmatic and cystic fibrosis patients, caused by an abnormal T-helper 2 lymphocyte response of the host to Aspergillus fumigatus antigens.
CINICOLA, BIANCA LAURA +3 more
core +1 more source
A systematic review of associations between environmental exposures and development of asthma in children aged up to 9 years [PDF]
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.Peer reviewedPublisher ...
AlKandari, F +7 more
core +1 more source
Bronchopulmonary dysplasia (BPD) is a chronic lung disease that predominantly affects prematurely born infants. Initially BPD was described in infants who had suffered severe respiratory failure and required high pressure, mechanical ventilation with ...
Anne eGreenough +2 more
doaj +1 more source

